Evans, Marc
Palaka, Eirini
Furuland, Hans
Bennett, Hayley
Linde, Cecilia
Qin, Lei
McEwan, Phil
Bakhai, Ameet
Funding for this research was provided by:
AstraZeneca (n/a)
Article History
Received: 13 September 2018
Accepted: 24 January 2019
First Online: 31 January 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: M. Evans declares no conflict of interest. E. Palaka is a full-time employee of AstraZeneca. H. Furuland has received modest research grant funding from AstraZeneca (as principal investigator), and modest expert witness funding from Amgen (as consultant). H. Bennett and P. McEwan have received significant research grant funding from AstraZeneca in relation to this study. C. Linde has received significant research grant funding from AstraZeneca (awarded to institution), and modest speaker honoraria from Biotronik, Medtronic, Abbot, Novartis and Vifor. L. Qin is a full-time employee of AstraZeneca, with modest ownership interests in AstraZeneca. A. Bakhai has received modest advisory honoraria from AstraZeneca in relation to this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.